Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 443 participants.
Also called NCT01092416
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 443 participants
- Sponsor
- Registry
-
NCT01092416
-
- Other papers using this trial's data
- ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System
- Outcomes After Orbital Atherectomy of Severely Calcified Left Main Lesions: Analysis of the ORBIT II Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01092416. Allocation not applicable; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2013-01 (actual). Results posted on 2016-01-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
- Acronym
- ORBIT II
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Diamondback 360 Orbital Atherectomy System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01092416- Content hash
f5da9cdc0097915e28f6d71ebd5175acc905cb1bd3747eed847bf6e338c62581